Paul Gavin
Company: Avecho Biotechnology
Job title: Chief Executive Officer
Seminars:
Panel Discussion: Overcoming Challenges for Pharmaceutical Engagement in R&D for Cannabinoid & Endocannabinoid System Targeting Drug Development 3:30 pm
How can pharma work with other stakeholders to de-risk investment in cannabinoid drug development? What actions can be taken to de-stigmatise cannabinoid drug development across large pharma? How have the first few breakthrough regulatory approvals paved the way for more widely accepted cannabinoid drug development within pharma? How can emerging technologies and innovative approaches within…Read more
day: Conference Day 1
CBD Dosage Forms: Oral, Transdermal & Buccal Transmucosal – Different Mechanisms to Increase Absorption 8:30 am
Investigating techniques and outcomes in clinical trials to improve bioavailability and absorption in oral, transdermal, and buccal transmucosal delivery systems Evaluating formulation strategies and technologies designed to optimize CBD absorption and onset of action through different routes of administration Comparative analysis of patient outcomes and absorption rates in clinical trials for oral, transdermal, and buccal…Read more
day: Day Two
Panel Discussion: Overcoming Challenges for Pharmaceutical Engagement in R&D for Cannabinoid & Endocannabinoid System Targeting Drug Development 3:30 pm
How can pharma work with other stakeholders to de-risk investment in cannabinoid drug development? What actions can be taken to de-stigmatise cannabinoid drug development across large pharma? How have the first few breakthrough regulatory approvals paved the way for more widely accepted cannabinoid drug development within pharma? How can emerging technologies and innovative approaches within…Read more
day: Day One PM